Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report.
作者信息
Stolwyk Kathleen, Lee Ikjae
机构信息
Department of Clinical Nutrition, New York Presbyterian Hospital, New York, NY, USA and.
Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
出版信息
Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):382-384. doi: 10.1080/21678421.2024.2446847. Epub 2025 Jan 7.
Abstract
摘要
相似文献
1
Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report.
Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):382-384. doi: 10.1080/21678421.2024.2446847. Epub 2025 Jan 7.
2
Skeletal muscle as a molecular and cellular biomarker of disease progression in amyotrophic lateral sclerosis: a narrative review.
Neural Regen Res. 2024 Apr;19(4):747-753. doi: 10.4103/1673-5374.382226.
3
A patient with amyotrophic lateral sclerosis and atypical clinical and electrodiagnostic features: a case report.
J Med Case Rep. 2011 Nov 2;5:538. doi: 10.1186/1752-1947-5-538.
4
Case report: Flail leg syndrome in familial amyotrophic lateral sclerosis with L144S mutation.
Front Neurol. 2023 Mar 22;14:1138668. doi: 10.3389/fneur.2023.1138668. eCollection 2023.
5
Pregnancy 5 Years After Onset of Amyotrophic Lateral Sclerosis Symptoms: A Case Report and Review of the Literature.
J Obstet Gynaecol Can. 2019 Jul;41(7):974-980. doi: 10.1016/j.jogc.2018.09.015. Epub 2018 Dec 7.
6
Illness trajectories in patients with amyotrophic lateral sclerosis: How illness progression is related to life narratives and interpersonal relationships.
J Clin Nurs. 2017 Dec;26(23-24):5033-5043. doi: 10.1111/jocn.14003. Epub 2017 Sep 29.
7
5'ValCAC tRNA fragment generated as part of a protective angiogenin response provides prognostic value in amyotrophic lateral sclerosis.
Brain Commun. 2020 Aug 28;2(2):fcaa138. doi: 10.1093/braincomms/fcaa138. eCollection 2020.
8
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3.
9
A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G.
Neural Regen Res. 2023 Jul;18(7):1527-1534. doi: 10.4103/1673-5374.357916.
10
Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation.
Neuropathol Appl Neurobiol. 2013 Aug;39(5):562-71. doi: 10.1111/nan.12007.
本文引用的文献
1
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies.
Diabetes Obes Metab. 2024 Sep;26 Suppl 4:16-27. doi: 10.1111/dom.15728. Epub 2024 Jun 27.
2
Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable.
JAMA. 2024 Jul 2;332(1):8. doi: 10.1001/jama.2024.10333.
3
Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.
Clin Diabetes. 2024 Spring;42(2):341-350. doi: 10.2337/cd23-0047. Epub 2023 Dec 5.
4
Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis.
Ann Neurol. 2024 Feb;95(2):217-229. doi: 10.1002/ana.26825. Epub 2023 Nov 29.
5
Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.
Am J Clin Nutr. 2022 May 1;115(5):1378-1392. doi: 10.1093/ajcn/nqac016.
6
Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.
PLoS One. 2021 May 6;16(5):e0251087. doi: 10.1371/journal.pone.0251087. eCollection 2021.
7
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort.
J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):666-673. doi: 10.1136/jnnp-2018-319611. Epub 2019 Jan 10.
8
Glucagon-like peptide 1 in health and disease.
Nat Rev Endocrinol. 2018 Jul;14(7):390-403. doi: 10.1038/s41574-018-0016-2.
9
Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):396-406. doi: 10.1080/21678421.2018.1452944. Epub 2018 Apr 16.
10
Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.
Am J Epidemiol. 2017 Mar 1;185(5):362-371. doi: 10.1093/aje/kww140.
Zotero 插件